RAB39A and osteosarcoma: ShRNA-based stable knockdown of RAB39A, CPVL, NUP210 and LHX2 significantly impaired cancer cell growth under neutral and acidic conditions in HOS human osteosarcoma cells (Figure 1C and 1D), but had no effect on the growth of normal cells (Supplementary Figure 1A).